Vivos Therapeutics, Inc. · NASDAQ:VVOS
V-Co Investors 4 LLC reported a 0.60% stake in Vivos Therapeutics, Inc. (Schedule 13D)
Event Jun 30, 2026 · Filed Jul 15, 2026
V-Co Investors 4 LLC reported a 0.60% stake in Vivos Therapeutics, Inc., 86,979 shares, with active intent on Jun 30, 2026. Filed Jul 15, 2026 (Schedule 13D).
- Stake
- 0.60%
- Shares
- 86,979
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| V-CO Investors LLC | 3.70% | 514,498 |
| V-Co Investors 2 LLC | 5.90% | 828,000 |
| V-Co Investors 3 LLC | 9.70% | 1,353,625 |
| V-Co Investors 4 LLC | 0.60% | 86,979 |
| SP Manager LLC | 19.90% | 2,783,102 |
| Michael C. Skaff | 19.90% | 2,783,102 |
Source
Related
- Vivos Therapeutics, Inc.
- V-Co Investors 4 LLC
- Vivos Therapeutics, Inc. shareholders
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026